CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Abbott signals $5.45-$5.60 2026 EPS outlook while targeting 6.5%-7.5% comparable sales growth

EarningsPositive
AI Analysis

Summary

Abbott issued 2026 EPS guidance of $5.45-$5.60 while targeting 6.5%-7.5% comparable sales growth for the year.

Financial Highlights

EPS

$5.45-$5.60

Guidance

6.5%-7.5% comparable sales growth

Importance:4/10
Sentiment:
0.50
earnings guidance2026 outlookfinancial guidance
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on July 16, 2026 5:17 PM

Read Original